Matthew Ferguson has served as our Chief Financial Officer since September 2020. Prior to joining us, Mr. Ferguson served as Chief Financial Officer for Bossa Nova Robotics, a privately held robotics company serving major retailers, from September 2018 to July 2020. From January 2011 to August 2018, Mr. Ferguson held various management positions, including Chief Financial Officer, Chief Business Officer and Co-President, at Avinger, Inc., a publicly traded cardiovascular medical device company. From 2009 to 2010, Mr. Ferguson served as Chief Financial Officer at Tethys Bioscience, a provider of molecular diagnostic tests for cardiometabolic conditions. From 2008 to 2009, Mr. Ferguson served as the Chief Financial Officer at Proteolix, a biotechnology company developing treatments for cancer and autoimmune diseases. Mr. Ferguson also served as the Chief Financial Officer and Vice President of Finance and Business Development at FoxHollow Technologies, a publicly traded medical device company, from 2002 through its merger with ev3 in 2007. Mr. Ferguson holds an M.B.A. from the University of California at Berkeley, an M.S. in Mechanical Engineering from the University of Pennsylvania and a B.S. in Civil Engineering from Stanford University.
From 2009 to 2010, Mr. Ferguson served as Chief Financial Officer at Tethys Bioscience, a provider of molecular diagnostic tests for cardiometabolic conditions. From 2008 to 2009, Mr. Ferguson served as the Chief Financial Officer at Proteolix, a biotechnology company developing treatments for cancer and autoimmune diseases. Mr. Ferguson also served as the Chief Financial Officer and Vice President of Finance and Business Development at FoxHollow Technologies, a publicly traded medical device company, from 2002 through its merger with ev3 in 2007. Mr. Ferguson holds a B.S. in Civil Engineering from Stanford University, an M.S. in Mechanical Engineering from the University of Pennsylvania and an M.B.A. from the University of California at Berkeley.
What is Matthew Ferguson's net worth?
The estimated net worth of Matthew Ferguson is at least $471.70 thousand as of December 17th, 2025. Mr. Ferguson owns 447,110 shares of Elutia stock worth more than $471,701 as of March 27th. This net worth approximation does not reflect any other assets that Mr. Ferguson may own. Learn More about Matthew Ferguson's net worth.
How do I contact Matthew Ferguson?
Has Matthew Ferguson been buying or selling shares of Elutia?
Matthew Ferguson has not been actively trading shares of Elutia over the course of the past ninety days. Most recently, on Wednesday, December 17th, Matthew Ferguson bought 60,000 shares of Elutia stock. The stock was acquired at an average cost of $0.53 per share, with a total value of $31,800.00. Following the completion of the transaction, the chief financial officer now directly owns 447,110 shares of the company's stock, valued at $236,968.30. Learn More on Matthew Ferguson's trading history.
Who are Elutia's active insiders?
Are insiders buying or selling shares of Elutia?
In the last year, Elutia insiders bought shares 13 times. They purchased a total of 299,500 shares worth more than $220,810.00. The most recent insider tranaction occured on January, 30th when Director Guido J Neels bought 20,000 shares worth more than $20,800.00. Insiders at Elutia own 27.6% of the company.
Learn More about insider trades at Elutia. Information on this page was last updated on 1/30/2026.
